» Articles » PMID: 1371769

Characterization of an Antigenically Conserved Heat-modifiable Major Outer Membrane Protein of Branhamella Catarrhalis

Overview
Journal Infect Immun
Date 1992 Mar 1
PMID 1371769
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Branhamella catarrhalis is a common cause of otitis media in children and of respiratory infections in adults with chronic bronchitis. Little is known about the antigenic structure of the outer membrane proteins (OMPs). In this study, two murine monoclonal antibodies, 7D6 and 5E8, were developed and used to characterize the major heat-modifiable OMP (OMP C/D) of B. catarrhalis. Immunoblot assays indicated that OMP C/D is heat modifiable, having a molecular mass of 55 kDa at room temperature and a mass of 60 kDa when heated under reducing conditions. Expression of the epitopes is independent of growth phase and growth media. Both epitopes are present in 51 of 51 strains of B. catarrhalis tested and are highly specific for Branhamella strains, being absent from a variety of other gram-negative species. Antibody 5E8 recognizes an epitope which is expressed on the surface of the intact bacterium. We conclude that OMP C/D is a major, heat-modifiable OMP antigen that expresses at least one stable, conserved epitope on the surface of B. catarrhalis. Future studies should focus on the role of OMP C/D in pathogenesis and on its potential role as a vaccine antigen.

Citing Articles

Otitis media: recent advances in otitis media vaccine development and model systems.

Zahid A, Wilson J, Grice I, Peak I Front Microbiol. 2024; 15:1345027.

PMID: 38328427 PMC: 10847372. DOI: 10.3389/fmicb.2024.1345027.


Vaccine targets against Moraxella catarrhalis.

Ren D, E Pichichero M Expert Opin Ther Targets. 2015; 20(1):19-33.

PMID: 26565427 PMC: 4720561. DOI: 10.1517/14728222.2015.1081686.


Moraxella catarrhalis expresses a cardiolipin synthase that impacts adherence to human epithelial cells.

Buskirk S, Lafontaine E J Bacteriol. 2013; 196(1):107-20.

PMID: 24142255 PMC: 3911130. DOI: 10.1128/JB.00298-13.


Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen.

Yang M, Johnson A, Murphy T Infect Immun. 2010; 79(2):846-57.

PMID: 21134967 PMC: 3028828. DOI: 10.1128/IAI.00314-10.


The immunogenicity of the liposome-associated outer membrane proteins (OMPs) of Moraxella catarrhalis.

Augustyniak D, Mleczko J, Gutowicz J Cell Mol Biol Lett. 2009; 15(1):70-89.

PMID: 19851720 PMC: 6276019. DOI: 10.2478/s11658-009-0035-z.


References
1.
Evans Jr F, Sydnor J, Moore W, MOORE G, Manwaring J, Brill A . Sinusitis of the maxillary antrum. N Engl J Med. 1975; 293(15):735-9. DOI: 10.1056/NEJM197510092931502. View

2.
Srinivasan G, Raff M, TEMPLETON W, Givens S, GRAVES R, Melo J . Branhamella catarrhalis pneumonia: report of two cases and review of the literature. Am Rev Respir Dis. 1981; 123(5):553-5. DOI: 10.1164/arrd.1981.123.5.553. View

3.
CATLIN B . Branhamella catarrhalis: an organism gaining respect as a pathogen. Clin Microbiol Rev. 1990; 3(4):293-320. PMC: 358165. DOI: 10.1128/CMR.3.4.293. View

4.
Wald E, BYERS C, Guerra N, Casselbrant M, Beste D . Subacute sinusitis in children. J Pediatr. 1989; 115(1):28-32. DOI: 10.1016/s0022-3476(89)80324-5. View

5.
Soto-Hernandez J, Harvill L, Berk S . Phenotypic characteristics of Branhamella catarrhalis strains. J Clin Microbiol. 1989; 27(5):903-8. PMC: 267452. DOI: 10.1128/jcm.27.5.903-908.1989. View